bufalin has been researched along with betadex in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Che, X; Liu, Y; Ma, Y; Qu, X; Teng, Y; Xu, L; Yan, S; Zhang, L; Zou, H | 1 |
Garamus, VM; Handge, UA; Willumeit-Römer, R; Yin, P; Zhao, X; Zou, A | 1 |
2 other study(ies) available for bufalin and betadex
Article | Year |
---|---|
Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; beta-Cyclodextrins; Breast Neoplasms; Bufanolides; Cell Line, Tumor; Cholesterol; Female; Humans; Membrane Microdomains; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand | 2014 |
Folate receptor targeted bufalin/β-cyclodextrin supramolecular inclusion complex for enhanced solubility and anti-tumor efficiency of bufalin.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Bufanolides; Calorimetry, Differential Scanning; Folic Acid; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2017 |